Karl Freimuth i Medtech Intelligence om M&A och robotteknik
Livingstones Karl Freimuth pratade med Medtech Intelligence om branschens främsta värdedrivande faktorer, möjligheter och utmaningar.
27/02/2019
Although medical device companies continue to be careful with their budgets, they are still on watch and are making room for strategic acquisitions that will bring a big boost to their portfolios. In a brief interview with MedTech Intelligence, Karl Freimuth, partner and co-head of the U.S. industrials practice at Livingstone, an independent M&A and advisory firm, expands on his latest report, “2018 Year in Review & 2019 Outlook” and what he sees as key industry drivers, challenges and opportunities.
Share on:
